These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35212160)

  • 21. Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma.
    Yu TJ; Liu YY; Hu X; Di GH
    Eur J Surg Oncol; 2018 Nov; 44(11):1703-1707. PubMed ID: 30029824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast-Conserving Therapy is Associated with Improved Survival Compared with Mastectomy for Early-Stage Breast Cancer: A Propensity Score Matched Comparison Using the National Cancer Database.
    Wrubel E; Natwick R; Wright GP
    Ann Surg Oncol; 2021 Feb; 28(2):914-919. PubMed ID: 32661849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer.
    Mahmood U; Morris C; Neuner G; Koshy M; Kesmodel S; Buras R; Chumsri S; Bao T; Tkaczuk K; Feigenberg S
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1387-93. PubMed ID: 22300561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study.
    Wang J; Wang X; Zhong Z; Li X; Sun J; Li J; Huang J; Li Y; Ren G; Li H
    Front Oncol; 2021; 11():642571. PubMed ID: 34458132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early-stage young breast cancer patients: impact of local treatment on survival.
    Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis.
    Luo Y; Chen X; Lv R; Li Q; Qian S; Xu X; Hou L; Deng W
    Breast Cancer; 2024 Sep; 31(5):979-987. PubMed ID: 38976120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
    World J Surg Oncol; 2017 Jul; 15(1):118. PubMed ID: 28673296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
    Saifi O; Chahrour MA; Li Z; Hoballah J; Panoff J; Vallow LA; Zeidan YH
    Breast; 2022 Apr; 62():144-151. PubMed ID: 35182994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
    Lagendijk M; van Maaren MC; Saadatmand S; Strobbe LJA; Poortmans PMP; Koppert LB; Tilanus-Linthorst MMA; Siesling S
    Int J Cancer; 2018 Jan; 142(1):165-175. PubMed ID: 28884470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival Outcomes of Breast-Conserving Therapy versus Mastectomy in Early-Stage Breast Cancer, Including Centrally Located Breast Cancer: A SEER-Based Study.
    Yu T; Cheng W; Wang T; Chen Z; Ding Y; Feng J; Duan Y; Hu A; Li M; Zhang H; Li Y; Ma F; Guo B
    Breast J; 2022; 2022():5325556. PubMed ID: 36101863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery.
    Orozco JIJ; Keller JK; Chang SC; Fancher CE; Grumley JG
    Ann Surg Oncol; 2022 Oct; 29(10):6299-6310. PubMed ID: 35896922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status.
    Hwang ES; Lichtensztajn DY; Gomez SL; Fowble B; Clarke CA
    Cancer; 2013 Apr; 119(7):1402-11. PubMed ID: 23359049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
    Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative radiotherapy versus no radiotherapy for early stage low-risk breast cancer patients undergoing breast-conserving surgery: a propensity score matching study based on the SEER database.
    Mi Y; Zuo X; Cao Q; He J; Sui X; Li J; Cui K; Ma X; Zhang N; Shi Y
    Clin Transl Oncol; 2022 Dec; 24(12):2409-2419. PubMed ID: 35962917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Better survival was found in patients treated with breast-conserving surgery compared with mastectomy in malignant phyllodes tumor of the breast.
    Chen CY; Ya-Chen
    Updates Surg; 2024 Jan; 76(1):265-270. PubMed ID: 37289397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer.
    Vasilyeva E; Nichol A; Bakos B; Barton A; Goecke M; Lam E; Martin E; Lohrisch C; McKevitt E
    Am J Surg; 2024 May; 231():70-73. PubMed ID: 37246127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm): A review of 5685 medicare patients.
    Bleicher RJ; Ruth K; Sigurdson ER; Daly JM; Boraas M; Anderson PR; Egleston BL
    Cancer; 2016 Jan; 122(1):42-9. PubMed ID: 26479066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
    van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
    Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
    Wang J; Tang H; Li X; Song C; Xiong Z; Wang X; Xie X; Tang J
    Cancer Commun (Lond); 2019 May; 39(1):25. PubMed ID: 31068224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.